Isaac Ro

Isaac Ro

Director/Board Member at SEER, INC.

Net worth: 76 670 $ as of 31/05/2026

48 year
Finance
Health Technology
Health Services

Profile

Isaac Ro is Executive Chairman at Haystack Oncology, Inc., Independent Director at Seer, Inc. (California) starting 2025, Director at Bioct Innovation Commons, and Partner at Catalio Capital Management LP since 2023.
Former roles include Director at Leerink Partners LLC from 2004 to 2010, Research Associate at Independence Investments LLC, Analyst at Goldman Sachs & Co. LLC.
from 2013 to 2019, Research Associate at Aberdeen Content LLC, Chief Financial Officer at Thrive Earlier Detection Corp.
from 2019 to 2021, and Chief Financial Officer at GeneDx Holdings Corp.
from 2021 to 2022.
Education includes an undergraduate degree from Middlebury College, conferred in 2000.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/09/2025 41,000 ( 0.07% ) 76 670 $ 31/05/2026

Isaac Ro active positions

CompaniesPositionStart
SEER, INC. Director/Board Member 02/09/2025
Bioct Innovation Commons
Director/Board Member -
Chairman -
Private Equity Investor 01/04/2023

Former positions of Isaac Ro

CompaniesPositionEnd
GENEDX HOLDINGS CORP. Director of Finance/CFO 10/06/2022
Director of Finance/CFO 01/02/2021
Analyst-Equity 01/06/2019
Analyst-Equity 31/05/2010
Corporate Officer/Principal -
See the detail of Isaac Ro's experience

Training of Isaac Ro

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

97

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Finance

Finance

Finance

Commercial Services

Consumer Services

Health Technology

Health Technology

Finance

Health Services

Bioct Innovation Commons

Finance

Health Services